{"name":"Vitrolife Group","slug":"vitrolife","ticker":"VITR","exchange":"Stockholm","domain":"vitrolife.com","description":"Vitrolife Group is a Swedish medical device company specializing in fertility and reproductive health solutions. The company's top products include embryo culture media, freezing equipment, and cryopreservation solutions. With a strong presence in the fertility market, Vitrolife Group is a key player in the industry.","hq":"Gothenburg, Sweden","founded":1984,"employees":"~1,000","ceo":"Bronwyn Brophy","sector":"Medical Devices / Fertility & Reproductive Health","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"153.4B","metrics":{"revenue":350000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-08","type":"earnings","headline":"Vitrolife Group Reports Q4 2023 Earnings","summary":"Vitrolife Group reported Q4 2023 earnings, with revenue increasing by 10% year-over-year.","drugName":"","sentiment":"positive"},{"date":"2023-09-01","type":"deal","headline":"Vitrolife Group Partners with Fertility Clinic","summary":"Vitrolife Group partnered with a leading fertility clinic to provide its embryo culture media and freezing equipment.","drugName":"","sentiment":"neutral"}],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-04-07","type":"deal","source":"simplywall.st","summary":"Assessing Vitrolife (OM:VITR) Valuation As The 2026 AGM Puts Governance And Buybacks In Focus - simplywall.st","headline":"Assessing Vitrolife (OM:VITR) Valuation As The 2026 AGM Puts Governance And Buybacks In Focus","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-17","type":"pipeline","source":"simplywall.st","summary":"European Stocks That May Be Trading Below Their Estimated Value In February 2026 - simplywall.st","headline":"European Stocks That May Be Trading Below Their Estimated Value In February 2026","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-05","type":"earnings","source":"simplywall.st","summary":"Vitrolife (OM:VITR) Q4 Loss Of SEK 5.3b Tests Bullish Turnaround Narratives - simplywall.st","headline":"Vitrolife (OM:VITR) Q4 Loss Of SEK 5.3b Tests Bullish Turnaround Narratives","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-29","type":"pipeline","source":"simplywall.st","summary":"European Value Stocks Trading Below Estimated Worth December 2025 - simplywall.st","headline":"European Value Stocks Trading Below Estimated Worth December 2025","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Cook Medical","Stryker","Boston Scientific"],"therapeuticFocus":["Fertility","Reproductive Health"],"financials":null,"yahoo":null}